Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antithrombin III | 2 | 2021 | 67 | 1.07 | Why? |
| Prothrombin | 2 | 2021 | 149 | 1.02 | Why? |
| Ischemic Attack, Transient | 2 | 2018 | 439 | 1.01 | Why? |
| Stroke | 12 | 2021 | 8839 | 0.85 | Why? |
| Carotid Artery, Internal | 1 | 2020 | 97 | 0.79 | Why? |
| Nocturnal Myoclonus Syndrome | 1 | 2018 | 10 | 0.74 | Why? |
| Unnecessary Procedures | 2 | 2017 | 175 | 0.72 | Why? |
| Nonprescription Drugs | 1 | 2018 | 78 | 0.67 | Why? |
| Carotid Artery Diseases | 1 | 2020 | 251 | 0.66 | Why? |
| Brain Ischemia | 5 | 2021 | 2813 | 0.65 | Why? |
| Peptide Hydrolases | 2 | 2021 | 1269 | 0.61 | Why? |
| Magnetic Resonance Angiography | 1 | 2017 | 282 | 0.59 | Why? |
| Acetaminophen | 1 | 2018 | 326 | 0.58 | Why? |
| Cerebral Angiography | 1 | 2017 | 391 | 0.57 | Why? |
| Analgesics | 1 | 2018 | 451 | 0.52 | Why? |
| Stroke Rehabilitation | 1 | 2016 | 299 | 0.50 | Why? |
| Peptide Fragments | 2 | 2021 | 2075 | 0.50 | Why? |
| Cerebral Hemorrhage | 1 | 2018 | 820 | 0.41 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.39 | Why? |
| Sleep Apnea, Obstructive | 1 | 2018 | 668 | 0.39 | Why? |
| Computed Tomography Angiography | 3 | 2021 | 2153 | 0.37 | Why? |
| Fibrin Fibrinogen Degradation Products | 3 | 2021 | 5993 | 0.36 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.34 | Why? |
| Perioperative Care | 1 | 2017 | 1329 | 0.32 | Why? |
| Echocardiography | 2 | 2018 | 3661 | 0.32 | Why? |
| Neurosurgical Procedures | 1 | 2017 | 1738 | 0.30 | Why? |
| Atrial Fibrillation | 2 | 2020 | 2320 | 0.29 | Why? |
| Heparin | 1 | 2017 | 2600 | 0.27 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.23 | Why? |
| Thrombolytic Therapy | 4 | 2021 | 2218 | 0.22 | Why? |
| Cerebral Revascularization | 1 | 2020 | 45 | 0.21 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.20 | Why? |
| Recurrence | 2 | 2020 | 3675 | 0.19 | Why? |
| Neurology | 2 | 2021 | 1613 | 0.19 | Why? |
| Powders | 1 | 2018 | 121 | 0.18 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.17 | Why? |
| Retinal Artery Occlusion | 1 | 2018 | 57 | 0.17 | Why? |
| Carotid Stenosis | 1 | 2020 | 207 | 0.17 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.17 | Why? |
| Exercise | 1 | 2016 | 6771 | 0.16 | Why? |
| Anticoagulants | 1 | 2017 | 9563 | 0.15 | Why? |
| Fibrinolysis | 1 | 2021 | 521 | 0.15 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2021 | 436 | 0.15 | Why? |
| Thrombelastography | 1 | 2021 | 627 | 0.15 | Why? |
| Syndrome | 1 | 2020 | 1310 | 0.14 | Why? |
| Aged | 15 | 2021 | 215776 | 0.14 | Why? |
| Predictive Value of Tests | 3 | 2021 | 9537 | 0.13 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.13 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.13 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.13 | Why? |
| Georgia | 1 | 2017 | 955 | 0.13 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.13 | Why? |
| Retina | 1 | 2018 | 424 | 0.13 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.12 | Why? |
| Thrombectomy | 2 | 2021 | 2272 | 0.12 | Why? |
| Intracranial Hemorrhages | 1 | 2021 | 1170 | 0.12 | Why? |
| Visual Acuity | 1 | 2018 | 790 | 0.11 | Why? |
| Registries | 3 | 2021 | 12327 | 0.11 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.11 | Why? |
| Female | 15 | 2021 | 380317 | 0.11 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.10 | Why? |
| Male | 14 | 2021 | 367725 | 0.10 | Why? |
| Stents | 1 | 2017 | 916 | 0.10 | Why? |
| Ischemia | 1 | 2018 | 901 | 0.10 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.10 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
| Thrombophilia | 1 | 2021 | 1935 | 0.09 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.09 | Why? |
| Exercise Therapy | 1 | 2016 | 976 | 0.09 | Why? |
| African Americans | 2 | 2020 | 3363 | 0.08 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.07 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2021 | 3543 | 0.07 | Why? |
| Blood Coagulation | 1 | 2018 | 2768 | 0.07 | Why? |
| Humans | 18 | 2021 | 930598 | 0.07 | Why? |
| Prognosis | 3 | 2018 | 32490 | 0.07 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.07 | Why? |
| Academic Medical Centers | 1 | 2017 | 3088 | 0.07 | Why? |
| Adult | 9 | 2021 | 244371 | 0.07 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.07 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.07 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.07 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.07 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.07 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Disease Management | 2 | 2020 | 6841 | 0.06 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.06 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.06 | Why? |
| Electrocardiography | 1 | 2017 | 3957 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.06 | Why? |
| Inpatients | 1 | 2017 | 5161 | 0.05 | Why? |
| Hospitals, Low-Volume | 1 | 2021 | 355 | 0.05 | Why? |
| Perfusion | 1 | 2021 | 254 | 0.05 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.05 | Why? |
| Embolism | 1 | 2020 | 136 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.05 | Why? |
| Hospitals, High-Volume | 1 | 2021 | 688 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.04 | Why? |
| Diagnostic Techniques, Ophthalmological | 1 | 2018 | 136 | 0.04 | Why? |
| Administration, Intravenous | 1 | 2020 | 1115 | 0.04 | Why? |
| Egypt | 1 | 2021 | 1211 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.04 | Why? |
| Tissue Plasminogen Activator | 1 | 2020 | 778 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Vascular Diseases | 1 | 2020 | 846 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Workflow | 1 | 2021 | 2373 | 0.03 | Why? |
| Fibrinolytic Agents | 1 | 2021 | 1702 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.02 | Why? |
| Patient Selection | 1 | 2021 | 4560 | 0.02 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2021 | 6551 | 0.02 | Why? |
| United States | 2 | 2021 | 46150 | 0.02 | Why? |
| Spain | 1 | 2021 | 15545 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
Nahab's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(352)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_